Reviewing Evolus (NASDAQ:EOLS) & Green Hygienics (OTCMKTS:GRYN)

Evolus (NASDAQ:EOLS) and Green Hygienics (OTCMKTS:GRYN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

Valuation & Earnings

This table compares Evolus and Green Hygienics’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolus	$184.73 million	3.03	-$74.41 million	($1.11)	-8.81
Green Hygienics	N/A	N/A	N/A	($0.25)	0.00

Green Hygienics has lower revenue, but higher earnings than Evolus. Evolus is trading at a lower price-to-earnings ratio than Green Hygienics, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

65.2% of Evolus shares are owned by institutional investors. Comparatively, 0.3% of Green Hygienics shares are owned by institutional investors. 5.4% of Evolus shares are owned by insiders. Comparatively, 0.3% of Green Hygienics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Evolus and Green Hygienics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolus	0	0	4	0	3.00
Green Hygienics	0	0	0	0	N/A

Evolus presently has a consensus target price of $21.40, suggesting a potential upside of 121.30%. Given Evolus’ higher possible upside, research analysts clearly believe Evolus is more favorable than Green Hygienics.

Profitability

This table compares Evolus and Green Hygienics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Evolus	-34.11%	-507.42%	-32.41%
Green Hygienics	N/A	N/A	N/A

About Evolus

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

About Green Hygienics

Green Hygienics Holdings, Inc., a development stage company, focuses on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol. The company was formerly known as Takedown Entertainment Inc. and changed its name to Green Hygienics Holdings Inc. in July 2012. Green Hygienics Holdings, Inc. was incorporated in 2008 and is headquartered in Poway, California. On July 11, 2023, Green Hygienics Holdings Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.